Patents by Inventor Daniel Floutard

Daniel Floutard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7825112
    Abstract: The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: November 2, 2010
    Assignee: sanofi-aventis
    Inventors: Pierre Casellas, Daniel Floutard, Pierre Fraisse, Stephane Hourcade, Samir Jegham
  • Patent number: 7777041
    Abstract: The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
    Type: Grant
    Filed: January 27, 2009
    Date of Patent: August 17, 2010
    Assignee: sanofi-aventis
    Inventors: Pierre Carayon, Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham, Bernard Labeeuw
  • Patent number: 7767681
    Abstract: The disclosure concerns 2-carbamide-4-phenylthiazole derivatives of general formula (I). The disclosure also concerns pharmaceutical compositions containing a compound of general formula (I) and to processes for preparing and methods of using compounds of general formula (I).
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: August 3, 2010
    Assignee: sanofi-aventis
    Inventors: Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham
  • Patent number: 7598392
    Abstract: The disclosure relates to 2-amido-4-phenylthiazole derivatives of general formula (I) below: in which R1, R2, R3, Y, m, n, and p are as defined in the disclosure; as well as to their isomers, salts and solvates, to the pharmaceutical compositions containing them and to the therapeutic use thereof.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: October 6, 2009
    Assignee: sanofi-aventis
    Inventors: Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham
  • Publication number: 20090156574
    Abstract: The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
    Type: Application
    Filed: January 27, 2009
    Publication date: June 18, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Pierre CARAYON, Pierre CASELLAS, Daniel FLOUTARD, Pierre FRAISSE, Samir JEGHAM, Bernard LABEEUW
  • Patent number: 7504511
    Abstract: The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
    Type: Grant
    Filed: October 19, 2005
    Date of Patent: March 17, 2009
    Assignee: Sanofi-Aventis
    Inventors: Pierre Carayon, Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham, Bernard Labeeuw
  • Publication number: 20090018117
    Abstract: The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
    Type: Application
    Filed: June 26, 2008
    Publication date: January 15, 2009
    Applicant: sanofi-aventis
    Inventors: Pierre CASELLAS, Daniel FLOUTARD, Pierre FRAISSE, Stephane HOURCADE, Samir JEGHAM
  • Publication number: 20070259847
    Abstract: The disclosure relates to 2-amido-4-phenylthiazole derivatives of general formula (I) below: in which R1, R2, R3, Y, m, n, and p are as defined in the disclosure; as well as to their isomers, salts and solvates, to the pharmaceutical compositions containing them and to the therapeutic use thereof.
    Type: Application
    Filed: April 18, 2007
    Publication date: November 8, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Pierre CASELLAS, Daniel FLOUTARD, Pierre FRAISSE, Samir JEGHAM
  • Publication number: 20070179126
    Abstract: The disclosure concerns 2-carbamide-4-phenylthiazole derivatives of general formula (I). The disclosure also concerns pharmaceutical compositions containing a compound of general formula (I) and to processes for preparing and methods of using compounds of general formula (I).
    Type: Application
    Filed: January 3, 2007
    Publication date: August 2, 2007
    Applicant: sanofi-aventis
    Inventors: Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham
  • Publication number: 20060135575
    Abstract: The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
    Type: Application
    Filed: October 19, 2005
    Publication date: June 22, 2006
    Applicant: Sanofi-Aventis
    Inventors: Pierre Carayon, Pierre Casellas, Daniel Floutard, Pierre Fraisse, Samir Jegham, Bernard Labeeuw